Anti- cancer therapy

NanoExpo offers High-Throughput Solutions for Protein Therapeutics Discovery and Development. To support anti-cancer therapy research our team is providing protein interaction screening using PeptAIm – a unique, AI-powered, bioinformatics platform that supports the design and development of molecular diagnostic tests. PeptAIm enables the selection of customized ligands-peptides with the highest affinity and spatial fit to the target receptor-protein allowing for peptide based therapeutic and biomarker discovery.